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Aortic Puncture and Paravalvular Leak
Closure With the New Amplatzer III Device
Bernhard Meier, MD,* Bernhard Winkler, MD,y Thierry Carrel, MD,y Christoph Huber, MDyA 72-year-old woman with a long-standing his-tory of rheumatic heart disease was admittedto our hospital for a severe paravalvular leak
(PVL). The patient contracted rheumatic fever in 1953
and received closed mitral commissurotomy in 1965,
mechanical aortic valve replacement with open mitral
commissurotomy in 1977, and mechanical mitralFIGURE 1 Perforation of the Ascending Aorta
(A) Perforation of the ascending aorta next to the right coronary ostium is
with the aortic puncture, and the blue line represents the guidewire pa
puncture. See Online Video 1.
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medically treated for endocarditis of the mitral valve
prosthesis but subsequently developed a severe PVL
of the mitral valve prosthesis and important concom-
itant hemolysis requiring 1 to 2 blood transfusions a
week. The patient was referred for reoperation in a
severely reduced clinical state. Surgical treatmentindicated by red asterisk (*). (B) The red line indicates the wire route
th through mitral valve annulus/paravalvular leak after transseptal
witzerland; and the yDepartment of Cardiovascular
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FIGURE 2 Amplatz GW Positioned in LV
(A) Following transseptal puncture, the Amplatz Extra-Stiff guidewire (GW) is positioned in the left ventricle (LV) through the paravalvular
leak. (B) An 8  4-mm Amplatzer Vascular Plug was implanted within the paravalvular leak in the mitral annulus. See Online Video 2.
AVP ¼ aortic valve prosthesis; MVP ¼ mitral valve prosthesis.
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e130as primarily recommended in this context of endo-
carditis can be associated with mortality rates
approaching 16% (1). Because of the increased
perioperative risk, a percutaneous transcatheter
approach was selected to close the PVL with an
Amplatzer Vascular Plug III device (St. Jude Medi-
cal, Plymouth, Minnesota) through a transseptal
approach (2).
The procedure was performed from the right
femoral vein, under general anesthesia, and guided
by transesophageal echocardiography. Accidental
perforation and dilation of the ascending aorta
next to the right coronary ostium was immediately
treated by insertion of a ﬁrst Amplatzer Vascular Plug
III ( Figures 1A, 1B, Online Video 1). After successful
transseptal puncture, the atrial septum was dilated,
an Amplatz Extra-Stiff guidewire (Cook Medical,Bloomington, Indiana) was positioned in the left
ventricle through the paravalvular leak (Figure 2A).
An 8  4 mm Amplatzer Vascular Plug III was then
successfully implanted within the PVL in the mitral
annulus (Figure 2B, Online Video 2). Transesophageal
echocardiography showed no paravalvular regurgita-
tion and a mean gradient of 4 mm Hg. Hospital stay
was uneventful, and the patient was discharged
7 days after the intervention. The patient was in
excellent condition without further symptoms and
without hemolysis 3 months after the intervention.
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APPENDIX For supplemental videos,
please see the online version of this article.
